350 related articles for article (PubMed ID: 33608752)
1. Screening and evaluation of anti-SARS-CoV-2 components from Ephedra sinica by ACE2/CMC-HPLC-IT-TOF-MS approach.
Lv Y; Wang S; Liang P; Wang Y; Zhang X; Jia Q; Fu J; Han S; He L
Anal Bioanal Chem; 2021 May; 413(11):2995-3004. PubMed ID: 33608752
[TBL] [Abstract][Full Text] [Related]
2. Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents.
Mei J; Zhou Y; Yang X; Zhang F; Liu X; Yu B
J Ethnopharmacol; 2021 Oct; 278():114303. PubMed ID: 34102269
[TBL] [Abstract][Full Text] [Related]
3. Repositioning of histamine H
Ge S; Wang X; Hou Y; Lv Y; Wang C; He H
Eur J Pharmacol; 2021 Apr; 896():173897. PubMed ID: 33497607
[TBL] [Abstract][Full Text] [Related]
4. Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro.
Lu J; Hou Y; Ge S; Wang X; Wang J; Hu T; Lv Y; He H; Wang C
Life Sci; 2021 Feb; 266():118889. PubMed ID: 33310043
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE2.
Zhang Y; Hu S; Wang J; Xue Z; Wang C; Wang N
Virology; 2021 Feb; 554():83-88. PubMed ID: 33387788
[TBL] [Abstract][Full Text] [Related]
6. Chemical composition and pharmacological mechanism of ephedra-glycyrrhiza drug pair against coronavirus disease 2019 (COVID-19).
Li X; Qiu Q; Li M; Lin H; Cao S; Wang Q; Chen Z; Jiang W; Zhang W; Huang Y; Luo H; Luo L
Aging (Albany NY); 2021 Feb; 13(4):4811-4830. PubMed ID: 33581688
[TBL] [Abstract][Full Text] [Related]
7. Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2.
Ge S; Lu J; Hou Y; Lv Y; Wang C; He H
Virology; 2021 Aug; 560():110-115. PubMed ID: 34052578
[TBL] [Abstract][Full Text] [Related]
8. In vitro anti-severe acute respiratory syndrome coronavirus 2 effect of Ephedra przewalskii Stapf extract.
Kakimoto M; Nomura T; Nazmul T; Yamamoto A; Sasaki H; Higashiura A; Ito M; Ohge H; Mikage M; Ogawa KO; Sakaguchi T
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117341. PubMed ID: 37879507
[TBL] [Abstract][Full Text] [Related]
9. Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2.
Ahmad S; Waheed Y; Abro A; Abbasi SW; Ismail S
J Mol Model; 2021 Jun; 27(7):206. PubMed ID: 34169390
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anti-SARS-CoV-2 activity of amino acid modified cephalotaxine derivatives.
Si M; An M; Xia Z; Mo X; Lu J; He H; Wang C
Chem Biol Drug Des; 2024 Jun; 103(6):e14566. PubMed ID: 38858134
[TBL] [Abstract][Full Text] [Related]
11. Three salvianolic acids inhibit 2019-nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2.
Hu S; Wang J; Zhang Y; Bai H; Wang C; Wang N; He L
J Med Virol; 2021 May; 93(5):3143-3151. PubMed ID: 33580518
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ACE2-Spike Interaction by an ACE2 Binder Suppresses SARS-CoV-2 Entry.
Shin YH; Jeong K; Lee J; Lee HJ; Yim J; Kim J; Kim S; Park SB
Angew Chem Int Ed Engl; 2022 Mar; 61(11):e202115695. PubMed ID: 35043545
[TBL] [Abstract][Full Text] [Related]
13. Potential antiviral activity of isorhamnetin against SARS-CoV-2 spike pseudotyped virus in vitro.
Zhan Y; Ta W; Tang W; Hua R; Wang J; Wang C; Lu W
Drug Dev Res; 2021 Dec; 82(8):1124-1130. PubMed ID: 33847382
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
Nayak SK
Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
[TBL] [Abstract][Full Text] [Related]
15. Oroxylin A is a severe acute respiratory syndrome coronavirus 2-spiked pseudotyped virus blocker obtained from Radix Scutellariae using angiotensin-converting enzyme II/cell membrane chromatography.
Gao J; Ding Y; Wang Y; Liang P; Zhang L; Liu R
Phytother Res; 2021 Jun; 35(6):3194-3204. PubMed ID: 33587321
[TBL] [Abstract][Full Text] [Related]
16. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
[TBL] [Abstract][Full Text] [Related]
17. Withanone from
Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
[TBL] [Abstract][Full Text] [Related]
18. Chemical constituents of the stems of Ephedra sinica.
Zhao W; Deng AJ; Du GH; Zhang JL; Li ZH; Qin HL
J Asian Nat Prod Res; 2009; 11(2):168-71. PubMed ID: 19219730
[TBL] [Abstract][Full Text] [Related]
19. Targeting SARS-CoV-2 Spike Protein/ACE2 Protein-Protein Interactions: a Computational Study.
Pirolli D; Righino B; De Rosa MC
Mol Inform; 2021 Jun; 40(6):e2060080. PubMed ID: 33904240
[TBL] [Abstract][Full Text] [Related]
20. A dual-target SPR screening system for simultaneous ligand discovery of SARS-CoV-2 spike protein and its receptor ACE2 from Chinese herbs.
Zhang Y; Wang D; Wang X; Ma H; Liu Y; Hong Z; Zhu Z; Chen X; Lv D; Cao Y; Chai Y
J Pharm Biomed Anal; 2024 Aug; 245():116142. PubMed ID: 38631070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
